|
Name |
cyclo[N-methyl-L-alanyl-beta-alanyl-(2R)-2-hydroxy-4-methylpentanoyl-(3S)-3-methyl-L-prolyl-L-isoleucyl-N-methyl-L-isoleucyl]
|
Molecular Formula | C32H55N5O7 | |
IUPAC Name* |
(3R,10S,13S,16S,19S,20S)-13,16-bis[(2S)-butan-2-yl]-10,11,14,20-tetramethyl-3-(2-methylpropyl)-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone
|
|
SMILES |
CC[C@H](C)[C@H]1C(=O)N([C@H](C(=O)N([C@H](C(=O)NCCC(=O)O[C@@H](C(=O)N2CC[C@@H]([C@H]2C(=O)N1)C)CC(C)C)C)C)[C@@H](C)CC)C
|
|
InChI |
InChI=1S/C32H55N5O7/c1-11-19(5)25-31(42)36(10)27(20(6)12-2)32(43)35(9)22(8)28(39)33-15-13-24(38)44-23(17-18(3)4)30(41)37-16-14-21(7)26(37)29(40)34-25/h18-23,25-27H,11-17H2,1-10H3,(H,33,39)(H,34,40)/t19-,20-,21-,22-,23+,25-,26-,27-/m0/s1
|
|
InChIKey |
AIPPDKJKKDOWTJ-MKUQIKACSA-N
|
|
Synonyms |
Homodestcardin; 917382-84-4; cyclo[N-methyl-L-alanyl-beta-alanyl-(2R)-2-hydroxy-4-methylpentanoyl-(3S)-3-methyl-L-prolyl-L-isoleucyl-N-methyl-L-isoleucyl]; (3R,10S,13S,16S,19S,20S)-13,16-bis[(2S)-butan-2-yl]-10,11,14,20-tetramethyl-3-(2-methylpropyl)-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone; HY-P3107; CS-0145449
|
|
CAS | NA | |
PubChem CID | 139586683 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 621.8 | ALogp: | 3.6 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 145.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 44 | QED Weighted: | 0.434 |
Caco-2 Permeability: | -5.209 | MDCK Permeability: | 0.00001130 |
Pgp-inhibitor: | 0.998 | Pgp-substrate: | 0.591 |
Human Intestinal Absorption (HIA): | 0.082 | 20% Bioavailability (F20%): | 0.047 |
30% Bioavailability (F30%): | 0.506 |
Blood-Brain-Barrier Penetration (BBB): | 0.126 | Plasma Protein Binding (PPB): | 84.76% |
Volume Distribution (VD): | 0.607 | Fu: | 3.75% |
CYP1A2-inhibitor: | 0.003 | CYP1A2-substrate: | 0.052 |
CYP2C19-inhibitor: | 0.088 | CYP2C19-substrate: | 0.727 |
CYP2C9-inhibitor: | 0.095 | CYP2C9-substrate: | 0.055 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.079 |
CYP3A4-inhibitor: | 0.901 | CYP3A4-substrate: | 0.566 |
Clearance (CL): | 6.608 | Half-life (T1/2): | 0.661 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.932 |
Drug-inuced Liver Injury (DILI): | 0.954 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.086 | Maximum Recommended Daily Dose: | 0.303 |
Skin Sensitization: | 0.096 | Carcinogencity: | 0.023 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.027 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003271 | 0.855 | D0O3YF | 0.274 | ||||
ENC003645 | 0.714 | D0L9HX | 0.271 | ||||
ENC003559 | 0.390 | D05AFC | 0.254 | ||||
ENC002857 | 0.388 | D08FJL | 0.252 | ||||
ENC005449 | 0.388 | D0L7LC | 0.251 | ||||
ENC003692 | 0.369 | D0P8IV | 0.245 | ||||
ENC002484 | 0.357 | D02SBQ | 0.243 | ||||
ENC002129 | 0.355 | D06YFA | 0.230 | ||||
ENC002373 | 0.353 | D00ZCN | 0.230 | ||||
ENC005563 | 0.347 | D0D8XY | 0.228 |